Managing Headache Disorders Associated with Tuberous Sclerosis and Neurofibromatosis

Area of Science:

• Neurology
• Neuro-oncology
• Genetics

Background:

• Tuberous sclerosis complex (TSC) and neurofibromatosis (NF) are common neurocutaneous disorders.
• Neurologists frequently manage these conditions in both pediatric and adult patients.

Purpose of the Study:

• To review common features of TSC and NF relevant to neurologists.
• To outline headache evaluation and management strategies for these disorders.

Main Methods:

• Review of current literature on TSC and NF, focusing on neurological manifestations and headache disorders.
• Analysis of diagnostic criteria and treatment modalities for associated headaches.

Main Results:

• Headaches in TSC are often secondary to intracranial tumors (e.g., subependymal giant-cell astrocytomas) or hydrocephalus.
• Neurofibromatosis type 1 (NF1) exhibits a higher prevalence of primary headache disorders, particularly migraine.
• Secondary headaches in NF1 can arise from neoplasms (gliomas) or vasculopathies (moyamoya syndrome).
• Emerging treatments like mTOR inhibitors for TSC and MEK inhibitors (Selumetinib) for NF1-associated gliomas are discussed.

Conclusions:

• Neurologists must be aware of the diverse headache presentations in TSC and NF.
• NF1 has a notable association with primary headaches, possibly linked to gene mutations affecting pain pathways.
• Management requires careful consideration of comorbidities and potential medication contraindications.